A federal magistrate in northern Indiana put a dent in E.I. du Pont de Nemours' defense on Thursday, recommending that courts deny parts of the company's bid to toss claims tied to decades of lead contamination at East Chicago's West Calumet site. The recommendation keeps negligence and emotional distress claims alive for residents and former students who say exposure harmed children and families. The report now heads to a district judge for a final decision.
Magistrate Backs Residents' Injury Claims
Magistrate Judge Abizer Zanzi wrote that "not all injuries must take the form of a medically diagnosed condition," and he rejected defendants' argument that plaintiffs needed a formal medical diagnosis to proceed, according to the Chicago Tribune. Zanzi recommended that the court allow parts of the state complaint to survive so that claims tied to confirmed lead exposure can move forward.
What The Lawsuit Alleges
The state complaint, filed in Lake Superior Court in 2022, names 11 plaintiffs who either lived at the West Calumet housing complex or attended the former Carrie Gosch Elementary School, and it seeks damages for negligence and emotional distress, according to the Chicago Tribune. Court records show that several plaintiffs say they tested positive for elevated lead in blood or bone samples as children and that some affected individuals now range roughly from 11 to 21 years old; those filings are publicly available on Justia.
Site History And Cleanup
The land where West Calumet once stood sits atop decades of industrial lead work, and the U.S. Environmental Protection Agency added the USS Lead area to the National Priorities List in 2009 before overseeing years of soil remediation, according to the U.S. EPA. Local reporting says the West Calumet complex was evacuated in 2016 and later demolished in 2018, and the city relocated residents while the EPA-led cleanup continued, details that have been chronicled by IPM/WFIU.
What Comes Next In Court
Zanzi's recommendation is a magistrate's report and not binding on its own. U.S. District Judge Philip Simon will decide whether to adopt it and determine which claims, if any, survive. If Simon accepts the recommendation, surviving counts would move into discovery, including depositions, expert reports, and document production, while adoption of the defendants' arguments could narrow or dismiss certain claims, according to Justia.
Why It Matters
The practical legal question is whether biomarker evidence, such as measured lead in blood or bone, can establish a legally recognizable injury without a formal medical diagnosis. Zanzi's recommendation leans toward letting such claims proceed. The litigation sits atop years of remediation and earlier agreements that required companies to fund cleanups, including multi-million-dollar settlements documented by the U.S. Department of Justice, and the district court's ruling could shape how similar exposure claims are handled nationwide.
